CD4 and pneumocystosis: A low incidence of primary PCP in patients receiving cART who had virologically suppressed HIV infection, with CD4 cell counts < 200 cells/mL, irrespective of prophylaxis, was suggested based on data presented in an observational HIV epidemiological research in Europe among patients with AIDS [54].